BiomX Inc. financial data

Symbol
PHGE on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
22 Einstein St., Floor 4, Ness Ziona, Israel
Fiscal year end
December 31
Former names
Chardan Healthcare Acquisition Corp. (to 10/23/2019)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 336 % +11.5%
Return On Equity -59.2 % +65.9%
Return On Assets -14.8 % +77.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.2M shares -60.5%
Common Stock, Shares, Outstanding 18.2M shares -60.5%
Entity Public Float 16.5M USD -11%
Common Stock, Value, Issued 6K USD +100%
Weighted Average Number of Shares Outstanding, Basic 16.4M shares +170%
Weighted Average Number of Shares Outstanding, Diluted 16.4M shares +170%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 21M USD +21.7%
General and Administrative Expense 11.4M USD +41.2%
Operating Income (Loss) -33.1M USD -29.2%
Nonoperating Income (Expense) 332K USD -13.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.69M USD +67.2%
Income Tax Expense (Benefit) 19K USD -68.9%
Net Income (Loss) Attributable to Parent -8.71M USD +67.2%
Earnings Per Share, Basic -1.15 USD/shares -163%
Earnings Per Share, Diluted -1.07 USD/shares -159%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.5M USD +4.84%
Cash, Cash Equivalents, and Short-term Investments 38.7M USD -18.1%
Other Assets, Current 3.67M USD +92.1%
Assets, Current 28.3M USD +11.9%
Property, Plant and Equipment, Net 6.58M USD +57.5%
Operating Lease, Right-of-Use Asset 9.7M USD +171%
Intangible Assets, Net (Excluding Goodwill) 382K USD -79.9%
Goodwill 801K USD
Other Assets, Noncurrent 96K USD
Assets 60M USD +81.5%
Accounts Payable, Current 1.36M USD -2.58%
Contract with Customer, Liability, Current 1.98M USD
Liabilities, Current 8.94M USD -30%
Contract with Customer, Liability, Noncurrent 1.98M USD 0%
Operating Lease, Liability, Noncurrent 8.65M USD +172%
Other Liabilities, Noncurrent 161K USD +8.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax -143M USD -22.7%
Retained Earnings (Accumulated Deficit) -166M USD -5.53%
Stockholders' Equity Attributable to Parent 37.9M USD +365%
Liabilities and Equity 60M USD +81.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.4M USD -125%
Net Cash Provided by (Used in) Financing Activities 39M USD +3612%
Net Cash Provided by (Used in) Investing Activities 663K USD -66.7%
Common Stock, Shares Authorized 750M shares +525%
Common Stock, Shares, Issued 18.2M shares -60.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.01M USD +88.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.7M USD +5.38%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42M USD +187%
Deferred Tax Assets, Valuation Allowance 32.1M USD +15.5%
Deferred Tax Assets, Gross 33.1M USD +14.6%
Operating Lease, Liability 3.91M USD -12.9%
Depreciation 632K USD +13.9%
Payments to Acquire Property, Plant, and Equipment 10K USD -50%
Lessee, Operating Lease, Liability, to be Paid 4.76M USD
Operating Lease, Liability, Current 1.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 688K USD -2.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 688K USD -2.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 853K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 688K USD -2.96%
Deferred Tax Assets, Operating Loss Carryforwards 29M USD +18.5%
Preferred Stock, Shares Issued 148K shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 688K USD -2.96%
Operating Lease, Payments 134K USD
Additional Paid in Capital 185M USD +12%
Preferred Stock, Shares Outstanding 148K shares
Amortization of Intangible Assets 1.52M USD 0%
Share-based Payment Arrangement, Expense 829K USD +325%
Interest Expense 2.69M USD +23.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%